Enhancement of type II substrate oxidation and of azo reduction in the isolated rat liver and in vitro by metyrapone.
D000814:Aniline Compounds / Q000378:metabolism; D000818:Animals; D001391:Azo Compounds / Q000378:metabolism*; D002248:Carbon Monoxide; D066298:In Vitro Techniques; D008099:Liver / Q000378:metabolism*; D008797:Metyrapone / Q000494:pharmacology*; D008862:Microsomes, Liver / Q000378:metabolism; D009282:Naphthalenesulfonates / Q000378:metabolism; D010084:Oxidation-Reduction; D010477:Perfusion; D010634:Phenobarbital / Q000494:pharmacology; D051381:Rats; D013997:Time Factors
D000814:Aniline Compounds; D001391:Azo Compounds; D009282:Naphthalenesulfonates; D002248:Carbon Monoxide; D010634:Phenobarbital; D008797:Metyrapone